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Mutations in peripheral myelin protein 22 (PMP22)
can result in the common peripheral neuropathy
Charcot-Marie-Tooth disease (CMTD). The Leu16Pro
mutation in PMP22 results in misassembly of the
protein, which causes the Trembler-J (TrJ) disease
phenotype. Here we elucidate the structural defects
present in a partially folded state of TrJ PMP22 that
are decisive in promoting CMTD-causing misfolding.
In this state, transmembrane helices 2–4 (TM2–4)
form amolten globular bundle, while transmembrane
helix 1 (TM1) is dissociated from this bundle. The TrJ
mutation was seen to profoundly disrupt the TM1
helix, resulting in increased backbone dynamics
and changes in the tertiary interactions of TM1 with
the PMP22 TM2–4 core in the folded state. Con-
sequently, TM1 undergoes enhanced dissociation
from the other transmembrane segments in TrJ
PMP22, becoming available for recognition and
sequestration by protein-folding quality control,
which leads to loss of function and toxic accumula-
tion of aggregates that result in CMTD.
INTRODUCTION
Peripheral myelin protein 22 (PMP22) is a 160 residue integral
membrane protein that is abundant in compact myelin of the
peripheral nervous system. PMP22 appears to be multifunc-
tional, playing roles in Schwann cell development and prolifera-
tion as well as in myelin formation and maintenance (Jetten and
Suter, 2000). PMP22 is essential to myelin homeostasis, as re-
flected by the fact that either trisomy or missense mutations of
its gene result in the most common inherited disease of the
peripheral nervous system, Charcot-Marie-Tooth disease
(CMTD), and related demyelinating neuropathies (Berger et al.,
2006).
CMTD results in dysmyelination and slowed nerve conduction
velocities (Berger et al., 2006). Whereas trisomy of the gene en-
coding PMP22 causes the common type 1A form of CMTD,more
rare inherited dominant missense mutations that encode single-
amino acid changes in the PMP22 protein cause closely related1160 Structure 19, 1160–1169, August 10, 2011 ª2011 Elsevier Ltd Adisorders (Naef and Suter, 1999; Sanders et al., 2001). Most
disease mutation sites are located in the transmembrane
segments. For example, replacement of leucine 16 with proline
near the middle of transmembrane helix 1 (TM1) causes both
severe CMTD in humans (sometimes classified as De´jerine-Sot-
tas syndrome) and the Trembler-J (TrJ) phenotype of peripheral
neuropathy in mice (Jetten and Suter, 2000; Suter et al., 1992;
Valentijn et al., 1992).
Wild-type (WT) PMP22 is believed to fold with only marginal
efficiency in vivo, even under healthy conditions. Approximately
80% of nascent WT is folding defective and targeted for degra-
dation by the protein-folding quality control system of the endo-
plasmic reticulum (ER) (Pareek et al., 1997). As is also the case
for most other CMTD mutant forms of PMP22, the TrJ mutation
is believed to reduce this normally modest folding efficiency to
near zero (Berger et al., 2006; Naef and Suter, 1999; Sanders
et al., 2001; Tobler et al., 1999). The resulting complete loss of
native PMP22 function is compounded by the fact that the mis-
folded TrJ mutant forms toxic aggregates rather than being
correctly degraded (D’Urso et al., 1998; Fortun et al., 2005,
2006; Notterpek et al., 1999), resulting in CMTD.
In previous work, it was established that both WT and TrJ
PMP22 are mostly helical proteins and that the folding stability
of the TrJ mutant is reduced relative to the WT protein in model
membranes at room temperature (Mobley et al., 2007; Myers
et al., 2008). Here we examine the structural properties of a
partially folded form of PMP22 to reveal that the Leu16Pro
mutation that underlies the TrJ disease phenotype profoundly
disrupts the protein’s first transmembrane segment (TM1), de-
stabilizing the protein and making TM1 available for sequestra-
tion by the protein-folding quality control apparatus of the endo-
plasmic reticulum.
RESULTS
Structural Properties of WT PMP22
WT and TrJ (L16P) PMP22 were purified (see Figure S1 available
online) and reconstituted as micellar complexes (Table S1) with
tetradecylphosphocholine (TDPC). Structural studies were
carried out under these conditions at 45C because it has previ-
ously been shown that both WT and TrJ forms of PMP22 yield
NMR spectra of reasonably high quality under these conditions
(Mobley et al., 2007). Here NMR was used to show that both
forms of PMP22 form a late-stage folding intermediate state
under these conditions in which transmembrane helices 2–4ll rights reserved
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Structural Basis of Charcot-Marie-Tooth Disease(TM2–4) populate a molten globular structural state while extra-
cellular loop 1 (ECL1) is largely disordered.
TROSY-based 3D NMR experiments (Figure S1) were used to
assign the backbone amide 1H, 13Ca,
13Cb, and
15N resonances
of WT PMP22. Out of 168 expected backbone amide 1H-15N
TROSY resonances from nonproline residues, 85 signals (51%)
were assigned (Figures 1A and 1B). Nearly all expected TROSY
resonances from the first transmembrane segment (TM1) and
first extracellular loop (ECL1) were observed and assigned.
However, most resonances from TM(2–4) and ECL2 were too
broad to detect. Both 1HN-
1HN nuclear Overhauser effect
(NOE) patterns and analysis of the assigned backbone chemical
shifts using TALOS+ (Shen et al., 2009) and chemical shift
indices (Wishart and Sykes, 1994) revealed that TM1 is a long
a helix that spans residues 1–30, whereas the first extracellular
loop is largely disordered and spans residues 31–57 (Figures
2A and 2B). Chemical shifts for the few observable resonances
from sites located at the beginning of TM2 and at the beginning
and ends of TM4 indicate that these transmembrane segments
are almost certainly helical as well, which is consistent with
far-UV circular dichroism (CD) measurements that indicate that
WT PMP22 is 63% a helical (Figure 3A).
The disappearance of nearly all TROSY resonances from
TM(2–4) could result either from an excessively large aggregate
molecular weight or from intermediate timescale exchange
between multiple conformations. NMR-based translational
diffusion coefficient measurements for the PMP22/TDPC
micellar complex were performed to determine its aggregate
molecular weight. The translational diffusion coefficient (Dt)
obtained for PMP22 in TDPC micelles was 7.7 (± 0.1) 3
1011 m2 s1, which corresponds to an aggregate molecular
weight of 58 kDa (Table S1). This aggregate molecular weight
is further supported by NMR relaxation measurements (see
below) and is reasonable because the size of protein-free
TDPC micelles has been reported to be 47 kDa (Strop and
Brunger, 2005). An apparent molecular weight of 58 kDa is
consistent with monomeric WT PMP22 inhabiting micelles
containing, on average, 102 TDPC molecules per micelle. It is
inconsistent with micelles containing dimeric PMP22, because
only 51 detergent molecules would be incorporated in the
complex. A weight of 58 kDa is well within the molecular weight
range for recording high-quality TROSY NMR spectra (Ferna´n-
dez and Wider, 2003). It can therefore be concluded that the
peaks from TM(2–4) are severely broadened not by slow molec-
ular tumbling but instead by intermediate timescale exchange
processes, which are characteristic of molten globular helical
bundles (Redfield, 2004). This interpretation is supported by
the fact that WT PMP22’s near-UV circular dichroism spectrum
at 45C (Figure 3B) is flat in the 260–310 nm range, as expected
for a molten globular protein.
The fact that TM1 and ECL1 yield easily detected TROSYNMR
peaks indicates that these structural elements populate states in
which they are dissociated from the molten globular domain.
This is supported by NMR relaxation measurements that
show that most sites in TM1 have 1H-15N NOEs well under 1.0
(Figure 2F). Moreover, the effective rotational correlation time
(16 ± 2 ns) calculated for TM1 from averaged backbone amide
15N T1 and T2 (Figures 2C–2E) is smaller by 20% than expected
based on the overall size of the PMP22/TDPC mixed micellesStructure 19, 1160–estimated from the translational diffusion coefficient, as ex-
pected if TM1 spends at least part of its time dissociated from
TM(2–4). For ECL1 the mobility is even higher, consistent with
this loop being largely disordered.
It is clear that at 45C TM1 of WT PMP22 significantly popu-
lates a state in which it is dissociated from tertiary structural
interactions with TM(2–4). This led to the question of whether it
also populates a state in which it interacts with TM(2–4). This
was probed by conducting saturation transfer difference (STD)
NMR experiments in which different protons of the TDPC deter-
gent were selectively irradiated while monitoring the TROSY
peaks from the protein. Reductions in the intensities of PMP22
TROSY peaks are indicative of direct detergent-residue interac-
tions between the associated protein site and the irradiated
moiety of the detergent. These measurements confirmed both
the facts that TM1 is a transmembrane segment and that ECL1
is largely water exposed (Figure 4; Figure S2). Moreover, the
STD data for TM1 exhibited a periodicity that indicates that
TM1 is interacting with TM(2–4) but that the interactive faces of
the C terminus and center of TM1 are offset by roughly 90
with respect to the long axis of an ideal helix (Figures S2D and
S2E). This likely indicates that the 30 residue TM1 is both tilted
and bent or curved. The fact that protection is for no site
complete (Figure 4) lends further support to the conclusion that
TM1 also populates a state where it is fully dissociated from
interacting with TM(2–4).
To summarize, at 45C and in TDPC micelles, TM segments
2–4 of WT PMP22 form a molten globule-like helical bundle.
TM1 forms a long a helix that interacts transiently with the
TM(2–4) bundle, but also spends a significant fraction of its
time freely dissociated. It is most likely that this structural state
represents a late-stage folding intermediate.
Structural Properties of the Leu16Pro Trembler-J CMTD
Form of PMP22
The general appearance of the 45C TROSY NMR spectrum for
the TrJ mutant form of PMP22 is similar to that of WT (Mobley
et al., 2007). Resonance assignments were completed for the
observed peaks which indicated that TrJ resembles the WT
protein in that, although a majority of peaks from TM1 and
ECL1 are observed, most peaks from TM(2–4) and ECL2 are
severely broadened (Figures 1C and 1D). Lack of ordered tertiary
structure is confirmed by the fact that the near-UV CD spectrum
does not deviate from the baseline (Figure 3B). This indicates
that the overall structures of TrJ and WT PMP22 at 45C in
TDPC micelles are similar: both forms populate what appears
to be a late-stage folding intermediate. The Leu16Pro CMTD
mutation clearly does not induce a catastrophic change in the
overall structure of TrJ PMP22 relative to WT. Nevertheless,
closer examination of the NMR data from TrJ PMP22 does reveal
significant local changes in protein structure and dynamics for
the mutant.
Whereas all resonances from TM1 are observable in the
TROSY spectrum of WT PMP22, for the TrJ/L16P mutant the
peaks from residues 8–17 in TM1 are absent as a result of severe
line broadening. Moreover, the chemical shifts of the observable
resonances in TM1 are significantly perturbed relative to WT
shifts (Figure 1E; Figure S3). These observations indicate that
the introduction of a proline at site 16 does more than just induce1169, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1161
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Figure 1. NMR Spectroscopy of WT and TrJ PMP22
(A) Panels from an 800MHz 1H-15N TROSYNMR spectrum ofWT PMP22 showing assigned backbone amide resonances. As for all NMR results presented in this
work, this spectrum was acquired using labeled (i.e., U-2H, 13C, 15N) PMP22 in TDPC micelles (pH 5.0 at 45C). The black and red lines indicate positive and
negative contours, respectively. Triple-resonance spectra used to assign the resonances are shown in Figure S1.
(B) Topology plot showing the approximate sequence spans of WT PMP22’s four transmembrane helices. Red residues yielded observable TROSY peaks that
were assigned for WT. White residues either failed to yield observable amide peaks or, less frequently, were observed but could not be assigned.
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Figure 2. NMR Analysis of PMP22 Secondary Structure andMotions
(A and B) Data used to determine WT PMP22’s secondary structure. The
diagrams above (A) show the locations of helices that are indicated by TALOS+
analysis (Shen et al., 2009) of the backbone/Cb chemical shifts and by
chemical shift index analysis based on 13Ca chemical shifts (Wishart and
Sykes, 1994). Dashed lines indicate regions where secondary structure cannot
Structure
Structural Basis of Charcot-Marie-Tooth Diseasea kink in the helix. On the other hand, far-UV CD indicates no
significant difference in overall a-helical content between WT
and TrJ (Figure 3A), suggesting that most sites in residues
8–17 remain helical. These observations can be reconciled if
the helix in the neighborhood of the mutation site is destabilized
such that it undergoes intermediate timescale exchange
between a predominant helical conformation and a less popu-
lated nonhelical structure, resulting in extensive amide peak
exchange broadening. This interpretation is supported both by
limited proteolysis data (below) and by 15N relaxation rate mea-
surements that show the helical ends of TM1 in the TrJ mutants
are significantly more mobile than these same segments in WT
(Figure 2E). This indicates that local destabilization of the helices
immediately adjacent to the Leu16Pro mutation site results in
formation of a flexible hinge that enables wagging motions of
the flanking TM1 helical segments.
As observed for WT, TM1 in the TrJ mutant form of PMP22
clearly populates a state in which it is dissociated from the
molten globular TM(2–4) domain. However, STD-NMR ex-
periments also confirmed that TM1 transiently interacts with
TM(2–4), as was seen for WT. For each of the helical segments
flanking the hinge associated with the Leu16Pro mutation it is
seen (Figure 4; Figure S2) that there is a helical face that contains
sites that are partially protected from saturation transfer from
detergent protons. However, the patterns of site protection
from STD are significantly different for the mutant than for WT.
In particular, at the C-terminal end, the protected face of the helix
appears to have rotated by at least 45 around the helical axis in
the TrJ mutant relative to WT (Figures S2D and S2G).
In summary, whereas the overall structure and dynamics of TrJ
PMP22 at 45C are not grossly different from those of the WT
protein, the L16P mutation results in formation of a hinge in the
middle of TM1, leading to wagging motions of the helices on
each side of the hinge and altered tertiary structural interactions
of TM1 with TM(2–4).
be determined because peaks were missing or unassigned.
(C–F) Data used to assess the motional dynamics of both WT and TrJ PMP22.
The 600 MHz backbone amide 15N NMR relaxation times were measured for
both WT PMP22 (black boxes) and the TrJ mutant (red circles). The effective
rotational correlation times and translational diffusion coefficients are shown in
Table S1. The error bars represent the calculated uncertainties associatedwith
the fitting of the T1 and T2 relaxation data (C–E) and with the direct experi-
mental measurement uncertainty in the case of the NOE data (F).Limited Proteolysis of WT and TrJ PMP22
WT and TrJ PMP22 were subjected to limited proteolysis using
pepsin under the same sample conditions as used for the NMR
experiments. It can be seen (Figures 5A and 5B) that TrJ
PMP22 is more rapidly degraded than WT. This is consistent
with the notion that TrJ is less stable than WT PMP22 and is
therefore more generally accessible to proteolytic digestion. It
is also seen that the pattern of bands observed for cleavage of
WT is different from that for TrJ. In order to more quantitatively
analyze the time course of cleavage, we subjected each proteo-
lytic digest of the time course to separation by liquid chromatog-
raphy followed by online electrospray tandem mass spectrom-
etry. These studies revealed that the 5 kDa band that is
generated at short times for TrJ (Figure 5B), but only in limited(C) Superimposed 800 MHz 1H-15N TROSY subspectra for TrJ PMP22 (red) and W
differences between WT and TrJ as shown by arrows, whereas residues such as
(D) Topological mapping of the residues in TrJ PMP22 affected by the L16Pmutatio
chemical shift differences between WT and TrJ of more than 0.1 ppm, 0.05–0.1
Residues with signals that disappeared in the mutant’s spectrum are colored ora
(E) Differences in 1H-15N TROSY chemical shifts between TrJ and WT PMP22.
Dd (= sqrt[(DdH)
2 + (DdN 3 0.18)
2]), where DdH and DdN represent the differences
forms of PMP22. Corresponding data for 13Ca are shown in Figure S3.
Structure 19, 1160–amounts for WT PMP22 (Figure 5A), is predominately the N
terminus of the protein up through residue 38 (Figures 5C and
5D) located in ECL1. More rapid generation of this 5 kDa frag-
ment for TrJ than the WT PMP22 was confirmed by multiple
LC-MS/MS analyses of pepsin digests for 30 min at 45C. Anal-
ysis of pepsin digests for 30 min at 25C gave a similar pattern.
These results indicate that the structural defects associated withT PMP22 (black). Residues such as I29 and V30 displayed large chemical shift
V15 were absent in the spectrum from the mutant because of line broadening.
n. The L16Pmutation site is highlighted by the black-filled circle. Residues with
ppm, and less than 0.05 ppm are colored red, yellow, and cyan, respectively.
nge.
The longitudinal axis represents the weighted differences in chemical shifts
in chemical shift for the amide 1H and 15N, respectively, between WT and TrJ
1169, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1163
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A B Figure 3. Near- and Far-UV CD Spectra of
WT and L16P (TrJ) PMP22 in TDPC Micelles
at 25C and 45C
Samples contained 50 mM acetate (pH 5).
Samples for far-UV CD (A) contained 10 mM (WT)
or 11 mM (L16P) PMP22, 0.5 mM DTT, and 0.2%
TDPC in 0.1 cm cuvettes. Samples for near-UV CD
(B) contained 37 mM (WT, 25C), 32 mM (WT, 45C),
or 48 mM (L16P, both temperatures) PMP22, 1 mM
DTT, 200 mM NaCl, and 1% TDPC in 1.0 cm
cuvettes. From the far-UV CD data, the a-helical
content of PMP22 was calculated to be 58% ± 1%
(WT, 25C), 56%± 1% (TrJ, 25C), 63%± 1% (WT,
45C), and 61% ± 1% (TrJ, 45C). The errors
represent the standard deviation calculated from
three different experimental data. The 25C
spectra closely resemble those reported for
PMP22 in a different type of micelle (dodecyl-
phosphocholine micelles) in Mobley et al. (2007).
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Structural Basis of Charcot-Marie-Tooth DiseaseTM1 in the L16P TrJ mutant result in ECL1 becoming more
accessible for proteolytic cleavage by pepsin. The increased
accessibility of residue 38 likely reflects the enhanced dissocia-
tion of TM1 from the TM(2–4) bundle in TrJ relative to WT, which
is likely accompanied by an increase in disorder and extension of
ECL1. The results of the proteolytic time course experiments
are fully consistent with the NMR experimental conclusions of
this work and previous evidence (Mobley et al., 2007; Myers
et al., 2008) that TrJ PMP22 is conformationally less stable
than WT.
DISCUSSION
The results of this study define the nature of the structural pertur-
bations in PMP22 that lead to the TrJ phenotype of CMTD.
Previous studies established that under micellar conditions
similar to those in this study but at lower temperature (25C),
WT PMP22 exhibits a more ordered tertiary structure in alkyl-
phosphocholine micelles than TrJ, as judged by near-UV CD
spectroscopy and by the fact that a partially reversible sigmoidal
unfolding curve is evident for WT but not for TrJ when a
denaturant is titrated into PMP22 solutions (Mobley et al.,
2007; Myers et al., 2008). A more detailed structural comparison
of the WT and disease mutant forms of the protein could not
be conducted at 25C using NMR spectroscopy because of
very poor spectral quality for both forms of that protein at that
temperature. Here we conducted structural studies at 45C,
a temperature at which PMP22’s NMR spectrum is more
optimal. At this higher temperature it was observed that both
WT and TrJ PMP22 adopt dynamic partially folded structures
that may resemble late-stage states in the folding pathway.
For both WT and TrJ, transmembrane segments 2–4 exist as
a molten globular helical bundle, whereas the first transmem-
brane segment populates two states—one in which it is dissoci-
ated from interactions with the TM(2–4) bundle and one in
which it undergoes transient interactions with TM(2–4). This is
summarized in Figure 6. If indeed this conformational ensemble
represents a folding intermediate, then it suggests that the
folding pathway for PMP22 involves an initial coalescence of
TM helices 2–4 to form a loosely packed helical bundle. Mature
tertiary interactions in this bundle are consolidated only at the1164 Structure 19, 1160–1169, August 10, 2011 ª2011 Elsevier Ltd Acompletion of folding, which involves the stable packing of
TM1 with the preformed TM(2–4) bundle.
Cell biological studies have established that even WT PMP22
folds in vivo with only marginal (20%) efficiency, with four out of
five newly synthesized molecules being deemed folding defec-
tive by the quality control machinery of the endoplasmic retic-
ulum, leading to targeting for degradation via the ERAD pathway
(Pareek et al., 1997). The low folding efficiency of WT PMP22 is
consistent with the general instability of WT PMP22 in detergent
micelles, as reflected by its marginal thermal stability (evidenced
by loss of ordered tertiary structure during the transition from
25C to 45C).
Whereas the overall structures of theWT and TrJmutant forms
of PMP22 are similar, the L16P mutation within TM1 of the TrJ
CMTD mutant dramatically alters both the conformation and
dynamics of TM1 (Figures 6A and 6B), leading to wagging
motions of the helices flanking the hinge-like mutation site and
to changes in the interface of TM1 that interacts transiently
with TM(2–4). This illuminates why the TrJ disease mutant form
of PMP22 folds with such a low (near 0%) efficiency under
cellular conditions (Colby et al., 2000; D’Urso et al., 1998; Tobler
et al., 2002). For proteins that fold in the ER, low folding efficiency
is thought to generally correlate well with low conformational
stability (Sanders and Myers, 2004; Wiseman et al., 2007). The
increased dynamics of TM1 in the TrJ mutant likely contributes
an entropic factor that disfavors the folded state relative to the
WT case (Figures 6C and 6D). The bend in TM1 that is induced
by the L16P mutation as well as the accompanying partial rota-
tion of the helix above site 16 (relative to WT) is also expected to
disrupt normal packing of TM1 with the TM(2–4) bundle, further
destabilizing the folded state of the TrJ mutant relative to WT,
consistent with our observations in both this and previous work.
Recognition and initial sequestration of both misfolded WT
and TrJ mutant forms in the ER appear to be carried out by the
membrane-associated lectin chaperone calnexin (Dickson
et al., 2002; Fontanini et al., 2005). It has been shown that in
sciatic nerves of the peripheral nervous system, calnexin binds
WT PMP22 to form a complex that has a t1/2 of 11 min, whereas
for the corresponding complex with the TrJ mutant the complex
is even longer lived, with a t1/2 of >60 min (Dickson et al., 2002).
For both WT and TrJ, TM1 appears to play a critical role asll rights reserved
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Figure 4. Results of STD-NMR Studies in Which the 1H-15N TROSY Peaks of PMP22 Were Monitored after Saturation Transfer from
Specifically Irradiated Moieties of the Host Detergent TDPC
Cyan-colored sites exhibited minimal saturation transfer (Isat/Iref > 0.9), indicating little or no contact between the indicated site and the relevant moiety of TDPC
that was irradiated. Yellow sites exhibited intermediate interactions (Isat/Iref = 0.8–0.9), whereas sites that exhibited themost intimate interactions (Isat/Iref < 0.8) are
colored red. (A)–(C) and (D)–(F) correspond to WT and TrJ PMP22, respectively. Reliable measurements could not be made for uncolored sites. (A) and (D)
correspond to presaturation of TDPC protons C1H2 (the carbon on the tetradecyl chain that is adjacent to the head group). (B) and (E) correspond to presaturation
of C4–13H2, whereas (C) and (F) correspond to presaturation of the terminal methyl group C
14H3 of the tetradecyl chain. The quantitative measurements that these
plots summarize are given in detail in Figure S2.
Structure
Structural Basis of Charcot-Marie-Tooth Diseasea structural element that is directly recognized by calnexin, and
synthetic polypeptides corresponding to TM1 of both WT and
TrJ are bound tightly by calnexin (Fontanini et al., 2005). The
present work establishes that TM1 is less avidly bundled with
TM(2–4) than these latter three TM segments are to each other.
It is therefore logical that calnexin assesses the state of foldingStructure 19, 1160–of PMP22 based on the accessibility of this TM segment. The
recognition of dissociated helices within multispan membrane
proteins by calnexin appears to be one of the mechanisms
used by ER quality control to recognize membrane proteins
that are incompletely folded or misfolded (Korkhov et al., 2008;
Li et al., 2010; Swanton et al., 2003). Our observation regarding1169, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1165
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Figure 5. Limited Proteolysis of PMP22
(A andB) SDS-PAGE gels giving the time course of limited proteolysis ofWT (A)
and TrJ (B) PMP22. TDPCmicellar solutions of WT (A) and TrJ (B) PMP22 were
exposed to pepsin for the amounts of time specified and then subjected to
SDS-PAGE followed by Coomassie staining (see Experimental Procedures for
additional details). Time courses were run at both 25C and 45C.
(C andD) LC-MS analysis of limited proteolytic digest ofWTPMP22 (C) and TrJ
(D). Selected-ion chromatograms for the molecular ion ([M+5H]5+ at m/z
1097.5 for TrJ [D] and m/z 1100.5 for WT [C]) corresponding to the N terminus
up through residue 38 (marked by an asterisk) generated after pepsin digestion
of 0.6 mg of PMP22 for 30 min at 45C. The tandem mass spectra identifying
the sequence of these peptides are presented in Figure S4.
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Figure 6. Model for How the L16P Mutation of TrJ PMP22 Results in
Destabilization of the Protein, Resulting in Enhanced Sequestration
by Calnexin
Structure
Structural Basis of Charcot-Marie-Tooth DiseaseTM1 dissociation may explain why both WT and TrJ PMP22
navigate ER quality control to fold and traffic beyond the ER
with only a low efficiency in vivo.
Whereas calnexin recognizes and associates with the TM1
segments of both WT and TrJ PMP22, kinetically persistent
binding of WT PMP22 also requires N-glycosylation of PMP22
in ECL1 (Fontanini et al., 2005). In contrast, the TrJ L16P mutant
is sequestered by calnexin in a manner that is independent of
N-glycosylation (Fontanini et al., 2005). This fact, along with
the observation that the t1/2 of the complex formed between
TrJ PMP22 and calnexin is at least five times longer than for
the complex with WT PMP22, suggests the intriguing possibility
that calnexin can not only recognize dissociated helices in multi-
span membrane proteins as a way of identifying incomplete or
incorrect folding but that calnexin may also bind more avidly to
helices that are structurally defective, such as in TrJ. It has previ-
ously been shown that calnexin can recognize TM segments that
have lipid-exposed acidic residues relative to mutants in which
the acidic side chain is replaced by a hydrophobic residue (Li
et al., 2010). Perhaps calnexin can recognize multiple forms of
defects in TM helices.
The conclusions of this paper lead to a satisfying model for
how the TrJ L16P mutation results in misfolding that ultimately
leads to CMTD (Figure 6). Whereas WT PMP22 is marginally
stable under healthy conditions in which its in vivo folding effi-
ciency is ca. 20%, the L16P mutation of TrJ PMP22 alters the
structure and dynamics of TM1 such that folding stability is
reduced to the point where the protein primarily inhabits a state
in which TM1 dissociates from interactions with TM2–4 and is
therefore fully available for recognition by calnexin. Local defects1166 Structure 19, 1160–1169, August 10, 2011 ª2011 Elsevier Ltd Ain the conformation of TM1 may also enhance the avidity of
binding by calnexin to further increase the efficiency by which
TrJ PMP22 is targeted to aggresomes. It will be interesting to
determine to what degree other CMTDmutations, many of which
are not in TM1, lead to alterations in PMP22 structure, stability,
and dynamics that resemble the perturbations documented in
this work for the TrJ mutant form. Finally, we also note that
missense mutations that encode insertions of proline residues
into the TM domains are an unusually common class of
disease-causing mutation (Partridge et al., 2002; Sanders,
2005). It is possible that the defects in TM1 observed as a result
of the L16P mutation in PMP22 may be shared by many other
disease-linked mutant membrane proteins.EXPERIMENTAL PROCEDURES
Expression and Purification of PMP22
Recombinant PMP22 was produced as a fusion protein with an N terminus
composed of the first 76 residues of the lambda repressor followed by a dec-
ahistidine tag, a thrombin cleavage site, a STREP tag, and then PMP22 (Fig-
ure S1A). Thrombin cleavage to remove the fusion partner was not possible
with a spacer (i.e., the STREP tag) between the cleavage site and the N
terminus of PMP22. This construct is slightly different from a construct we
previously reported (Mobley et al., 2007) in that a thrombin site now replaces
a TEV protease site. Protein expression was carried out in RosettaBlue
Escherichia coli (EMD Chemicals) grown at 20C in M9 minimal media withll rights reserved
Structure
Structural Basis of Charcot-Marie-Tooth Disease100 mg/ml ampicillin and 50 mg/ml chloramphenicol and supplemented with an
MEM vitamin (Mediatech). Isopropylthiogalactoside was used to induce
expression. Uniformly 2H-, 13C-, and 15N-labeled protein was expressed in
D2O-based M9 medium containing 1 g/l [
15N]ammonium chloride and 3 g/l
[13C]glucose. Amino acid selectively labeled proteins were expressed in M9
media supplemented with a combination of both labeled and unlabeled amino
acids as described (Czerski et al., 2000). Cys, His, Lys, Met, Tyr, Val, and Trp
were targeted for selective main-chain 15N labeling.
Following harvesting, cells were resuspended in lysis buffer (75mMTris-HCl
[pH 7.5], 300 mM NaCl, 0.2 mM EDTA, 10 mM BHT) at 20 ml/g of cell pellet.
Lysozyme (0.2 mg/ml of total lysis buffer), RNase (0.02 mg/ml), DNase
(0.02 mg/ml), and magnesium acetate (5 mM) were added, and the solution
was rotated at 4C for 30 min. The lysate was then sonicated on ice for
10 min. DTT was then added to a concentration of 0.5 mM. To extract the
fusion protein, glycerol was added to 15% and Empigen (a detergent; Fluka)
to 3%, and the solution was rotated at 4C for 45 min. After centrifugation at
20,000 rpm (48,384 3 g) and 4C for 20 min, the supernatant was collected.
Ni-NTA resin (QIAGEN; 1.2 ml of resin/g of cell pellet) was added to the lysate
and this mixture was rotated at 4C for 45 min. Resin was packed into a chro-
matography column and washed first with 10 column volumes of Empigen/A
buffer (40 mM HEPES [pH 7.5], 300 mM NaCl, 15% glycerol, 3% Empigen,
and 0.5 mM DTT) and second with wash buffer (40 mM HEPES [pH 7.8],
300 mM NaCl, 15% glycerol, 1.5% Empigen, 30 mM imidazole, and 0.5 mM
DTT) until the measured absorbance at 280 nm indicated complete elution
of weakly bound impurities, usually 10 column volumes. Detergent was
then exchanged from Empigen to dodecylphosphocholine (DPC; Anatrace)
by passing 10 column volumes of rinse buffer (25 mM sodium phosphate
[pH 7.2], 0.5% DPC, and 0.5 mM DTT) through the column. The PMP22 fusion
protein was eluted from the column using elution buffer (50 mM Tris-HCl [pH
8.0], 250 mM imidazole, 0.5% DPC, and 0.5 mM DTT). The eluted protein
concentration was determined bymeasuring A280 nm using the extinction coef-
ficient of 1.64 ml mg1 cm1. The eluate was diluted with a solution containing
0.5% DPC and 0.5 mM DTT to make a solution containing 0.8 mg/ml of the
fusion protein.
Cleavage of the fusion partner from PMP22 was performed by adding
a stock solution containing 50% glycerol, 2 mM EDTA, 0.5 mM DTT, and
50 NIH units/ml thrombin (Sigma; thrombin from human plasma, >2800 NIH
units/mg protein). The final reaction buffer typically contained 0.4mg/ml fusion
PMP22, 25 NIH units/ml thrombin, 11 mM Tris (pH 8), 53 mM imidazole,
0.5 mM DTT, 1 mM EDTA, 0.25% DPC, and 25% glycerol. The pH of the
solution was then adjusted to 5.0 and cleaved PMP22 was purified by
cation-exchange chromatography using an SP-Sepharose cation-exchange
column (GE Healthcare Life Sciences). Following sample loading, the column
was washed with 20 column volumes of buffer containing 50 mM acetate (pH
5.0), 0.2% TDPC, and 1 mM DTT to exchange detergent from DPC to TDPC.
Cleaved PMP22 was then eluted by elevating (as a gradient) the NaCl concen-
tration to 200 mM. Remaining uncleaved fusion protein was then removed
from the eluate from the cation-exchange column by adding Ni-NTA resin
(0.7 ml resin/20 ml of PMP22 solution) and then gently mixing at 4C for
45 min. After removal of the resin, the PMP22 solution was concentrated in
a 10 kDa MWCO Amicon Ultra-4 centrifugal filtering device (Millipore). The
buffer was then exchanged into 10 mM acetate (pH 5.0), 10 mM DTT, 1 mM
EDTA, and 5% D2O by multiple centrifugal ultrafiltration exchanges during
which extra detergent was not added. This was the final step in preparing
the NMR samples used in these studies. The final PMP22 and TDPC con-
centrations were typically 0.81.0 mM and 284395 mM (11%15%),
respectively.NMR Measurements
All NMR measurements were carried out at 45C. Data were collected on
Bruker Avance 600 and 800 spectrometers equipped with cryogenic triple-
resonance probe heads with z axis pulsed-field gradients. Diffusion experi-
ments were carried out on an Avance 600 spectrometer with a conventional
triple-resonance probe with z-axis pulsed-field gradient. The spectra were
processed using TopSpin (http://www.bruker-biospin.com/topspin-overview.
html) and analyzed with Sparky (http://www.cgl.ucsf.edu/home/sparky).
Chemical shifts were referenced to DSS as described (Edison et al., 1994).Structure 19, 1160–Two-dimensional 1H-15N TROSY experiments were carried out at 600 and
800 MHz using a sensitivity- and gradient-enhanced TROSY pulse sequence
(Weigelt, 1998). Spectra are typically acquired with 128 complex points and
an acquisition time of 56 ms in the 15N dimension and 1024 complex points
and an acquisition time of 80 ms in the observed dimension.
Triple-resonance TROSY versions of HNCA, HN(CO)CA, HNCACB, and
HN(CO)CACB experiments (Eletsky et al., 2001; Salzmann et al., 1999) were
carried out for 2H-, 13C-, and 15N-labeled WT PMP22 in TDPC micelles at
800 MHz. For L16P PMP22, TROSY versions of HNCA and HN(CO)CA were
recorded. Triple-resonance experiments were acquired with 32 complex
points and an acquisition time of 14.1 ms in the 15N dimension, and 512
complex points and an acquisition time of 40 ms in the observed dimension.
Experiments with 13Ca and
13Ca/
13Cb evolution were acquired with 32 and
58 complex points and acquisition times of 6.63 and 4.37 ms in the 13C dimen-
sion, respectively. A 1H-15N NOESY-TROSY (Chill et al., 2006; Zhu et al., 1999)
spectrumwas acquired at 800MHz field with amixing time of 80ms. The spec-
trumwas acquired with 128 complex points and an acquisition time of 26.7 ms
in the indirect 1H dimension, 32 complex points and an acquisition time of
14.1 ms in the 15N dimension, and 1024 complex points and an acquisition
time of 91.8 ms in the 1H observed dimension. An E-BURP pulse was used
as the first 1H pulse to selectively excite amide protons in the NOESY experi-
ment as described (Chill et al., 2006).
HSQC-based T1, T2, and
15N-(1H) NOE experiments were carried out for
15N-labeled PMP22 (WT or L16P) at 600 MHz. The TDPC concentration was
290 and 284 mM for WT and the L16P mutant, respectively. Gradient-
enhanced versions of pulse programs with improved sensitivity were used
for these experiments (Farrow et al., 1994; Kay et al., 1992). T1 values were
determined from a series of spectra with 0.1, 0.2, 0.4, 0.8, 1.2, 1.6, and 2.0 s
relaxation delays. T2 values were obtained from the spectra with 0, 8.6, 17,
35, 69, 138, and 199 ms relaxation delays. For the L16P (TrJ) mutant, T2
data for an additional relaxation delay of 104 ms were also collected. An
additional delay of 1.2 s between scans was also employed when measuring
15N T1 and T2 values.
15N-(1H) NOE values were determined from the intensity
ratios between signals in the spectrum acquired using 3 s proton presaturation
relative to the corresponding signals in the reference spectrum acquired
without presaturation. All spectra were recorded as 128 (15N) 3 1024 (1H)
complex points with 32 scans per t1 point for the T1/T2 experiments and 24
scans for the NOE experiment. Spectral widths were 1703 and 9615 Hz in
the 15N and 1H dimensions, respectively.
Diffusion experiments were carried out for 15N-labeled PMP22 in 276 mM
TDPC micelles at 600 MHz. Two-dimensional 1H-15N-DOSY-HSQC (Brand
et al., 2007) pulse schemes employing bipolar pulse pair longitudinal eddy-
current delays (BPPLED) (Wu et al., 1995) followed by the sensitivity-enhanced
HSQC unit (Schleucher et al., 1994) were used to measure the translational
diffusion coefficient (Dt) of PMP22. The detergent Dt was measured by
2D-BPPLED. For 2D experiments, a series of 32 diffusion-weighted one-
dimensional spectra with 4096 complex points were recorded in a two-dimen-
sional manner, using a gradient pulse length of 3.5ms, a 110ms diffusion delay
between the first 90 pulses of the two BPP units (large delta), and an interscan
delay of 6 s. The pulsed-field gradient (PFG) strength was varied from 0.76 to
36 G/cm. PFG strength was obtained by back-calculating the diffusion coeffi-
cient of 1% H2O (1.905 3 10
9 m2 s1 at 25C) (Longsworth, 1960) using a
solution containing 1% 1H2O, 99%D2O, and 0.1mg/ml GdCl3. Spectral widths
were 1703 and 9615 Hz in 15N and 1H dimensions, respectively. NMR signal
integrals from 6.5 or 6.7 to 9 ppm were used for analysis of the 2D diffusion
data. Dt was obtained by fitting the data to the theoretical formula as described
(Wu et al., 1995).
Saturation transfer difference (STD) NMR experiments were carried out for
2H-, 13C-, and 15N-labeled PMP22 in TDPC micelles at 600 MHz field. TDPC
protons were selectively irradiated in continuous-wave mode for 2 s and the
amide proton signals of the protein were detected by the TROSY pulse
scheme following the irradiation (Sakakura et al., 2008). The delay for relaxa-
tion between scans was set to 2 s. Selective irradiation was applied at
0.84 ppm for the C(14)H3 of TDPC, 1.25 ppm for the C
(4–13)H2, and 3.82 ppm
for the C(1)H2. TROSY spectra with and without saturation were recorded in
interleaved fashion.
Secondary structure was analyzed by calculating deviations of the observed
13Ca chemical shifts from their residue-dependent random coil values (DCa)1169, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1167
Structure
Structural Basis of Charcot-Marie-Tooth Disease(Wishart and Sykes, 1994). The TALOS+ program (Shen et al., 2009) was also
used to assess the secondary structure using 13Ca,
13Cb, and
15NH chemical
shifts as input data.
The secondary chemical shifts of amide protons were calculated by sub-
tracting random coil values from the shifts measured in the TROSY spectrum
of 2H-, 13C-, and 15N-labeled samples (Wishart et al., 1991; Zhou et al., 1992).
Corrections were made for the 1JNH/2 shifts of the TROSY.
The effective rotational correlation time of TM1 was calculated using the
averaged backbone 15N T1/T2 ratio for residues from Lys3 through Ile29
with the program r2r1_tm (http://biochemistry.hs.columbia.edu/labs/palmer/
software/r2r1_tm.html).
Circular Dichroism Measurements
CD experiments were carried out using a Jasco J-810 instrument with a Peltier
temperature control unit. For far-UV, CD samples were added to a 0.1 cm
path-length quartz cuvette (Hellma) and spectra were acquired from 185 nm
to 260 nm at 25C and 45C with a 1.5 nm bandwidth, averaging for 4 s at
each wavelength. Three spectra were averaged to give the final trace, and
blank spectra were subtracted. Protein concentrations were 10 and 11 mM
for WT and L16P PMP22, respectively. The protein solutions contained
50 mM acetate (pH 5), 0.5 mM DTT, and 0.2% TDPC. The fractional helicity
was calculated as described (Rohl and Baldwin, 1997).
For near-UV, CD samples were added to a 1.0 cm path-length quartz
cuvette (Hellma) and spectra were acquired over the range of 255 nm to
330 nm at 25C and 45C with a 1 nm bandwidth, averaging for 4 s at each
wavelength. Three spectra were averaged to give the final trace, and blank
spectra were subtracted. Protein concentrations were 37, 32, and 48 mM for
WT (25C), WT (45C), and L16P PMP22, respectively. The protein solutions
contained 50 mM acetate (pH 5), 1.0 mM DTT, and ca. 200 mM NaCl. TDPC
concentrations were 1.0% (WT, 25C), 0.9% (WT, 45C), and 0.9% (L16P).
Limited Proteolytic Cleavage of PMP22
PMP22 (0.6mg/ml) was digested with pepsin (0.6 mg/ml) (Sigma; pepsin A from
porcine stomach mucosa, 3100 units/mg). Pepsin cleavage was carried out in
a solution containing 50 mM acetate (pH 5), 0.6/0.4% TDPC (for WT/L16P),
and 0.5 mM DTT. At a series of time points (30 min, 1 hr, 2 hr, 4 hr, and
20.5 hr), the reactions were terminated by raising the pH with 20 mM NaOH
and heating the samples at 95C for 1 min. The cleaved protein fragments
were separated by SDS-PAGE and the amount of protein fragments loaded
on the gel corresponded to 7 mg of PMP22 (Invitrogen; NuPAGE, 10% bis-
Tris gel).
Mass Spectrometry to Analyze the Time Course of Proteolysis
of PMP22
Direct analysis of peptic digests obtained from digestion of 0.6 mg of PMP22
was carried out by LC-MS/MS after sample cleanup using a C4 Ziptip (Milli-
pore) and elution in 70% acetonitrile (ACN) (0.1% formic acid). The eluate
was dried in a speedvac and reconstituted in 0.1% formic acid and loaded
onto a custom-packed C8 trap column (5 cm 3 100 mm, Jupiter C8, 3 mm,
100 A˚ media). The trap column was coupled to a nanoflow analytical column
(11 cm 3 75 mm, Jupiter C8, 3 mm, 100 A˚ media). Liquid chromatography
was performed using the following gradient at a flow rate of 0.4 ml/min:
0–2 min: 2% ACN (0.1% formic acid); 2–30 min: 2%–35% ACN (0.1% formic
acid); 30–75 min: 35%–90% ACN (0.1% formic acid). The eluate was directly
infused into an LTQ Velos ion-trap mass spectrometer (Thermo Scientific),
which was operated in data-dependent mode for all the analyses with the
top six most abundant ions in each MS scan selected for fragmentation in
the LTQ. Peptides were identified by manual interpretation with the assistance
of Proteome Discoverer (Thermo Scientific). Selected-ion chromatograms
were plotted for TrJ and WT peptides, and the intensities were used to quan-
titate differences in digestion efficiency at specific cleavage sites.
ACCESSION NUMBERS
NMR assignments for the WT and Leu16Pro (Trembler-J) forms of PMP22
have been deposited in the BioMagResBank (http://www.bmrb.wisc.edu)
under ID code 17454 for WT and ID code 17455 for L16P.1168 Structure 19, 1160–1169, August 10, 2011 ª2011 Elsevier Ltd ASUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.str.2011.05.009.
ACKNOWLEDGMENTS
We thank K. Danielle Kelley for technical assistance, Dr. Wade Van Horn for
useful discussion, and Professors Jun Li and Bruce Carter for helpful
comments. This work was supported by a postdoctoral fellowship to M.S.
(long-term research grant) from the Toyobo Biotechnology Foundation and
by U.S. NIH grants R01 GM47485 and R01 NS058815 (to C.R.S.) and R01
EY13462 (to K.L.S.). The authors declare no conflict of interest.
Received: April 13, 2011
Revised: May 19, 2011
Accepted: May 24, 2011
Published: August 9, 2011
REFERENCES
Berger, P., Niemann, A., and Suter, U. (2006). Schwann cells and the patho-
genesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth
disease). Glia 54, 243–257.
Brand, T., Cabrita, E.J., Morris, G.A., Gu¨nther, R., Hofmann, H.J., and Berger,
S. (2007). Residue-specific NH exchange rates studied by NMR diffusion
experiments. J. Magn. Reson. 187, 97–104.
Chill, J.H., Louis, J.M., Miller, C., and Bax, A. (2006). NMR study of the tetra-
meric KcsA potassium channel in detergent micelles. Protein Sci. 15, 684–698.
Colby, J., Nicholson, R.,Dickson, K.M.,Orfali,W.,Naef, R., Suter, U., andSnipes,
G.J. (2000). PMP22 carrying the trembler or trembler-J mutation is intracellularly
retained in myelinating Schwann cells. Neurobiol. Dis. 7 (6 Pt B), 561–573.
Czerski, L., Vinogradova, O., and Sanders, C.R. (2000). NMR-based amide
hydrogen-deuterium exchange measurements for complex membrane
proteins: development and critical evaluation. J. Magn. Reson. 142, 111–119.
Dickson, K.M., Bergeron, J.J., Shames, I., Colby, J., Nguyen, D.T., Chevet, E.,
Thomas, D.Y., and Snipes, G.J. (2002). Association of calnexin with mutant
peripheral myelin protein-22 ex vivo: a basis for ‘‘gain-of-function’’ ER
diseases. Proc. Natl. Acad. Sci. USA 99, 9852–9857.
D’Urso, D., Prior, R., Greiner-Petter, R., Gabree¨ls-Festen, A.A., and Mu¨ller,
H.W. (1998). Overloaded endoplasmic reticulum-Golgi compartments, a
possible pathomechanism of peripheral neuropathies caused by mutations
of the peripheral myelin protein PMP22. J. Neurosci. 18, 731–740.
Edison, A.S., Abildgaard, F., Westler, W.M., Mooberry, E.S., and Markley, J.L.
(1994). Practical introduction to theory and implementation of multinuclear,
multidimensional nuclear magnetic resonance experiments. Methods
Enzymol. 239, 3–79.
Eletsky, A., Kienho¨fer, A., and Pervushin, K. (2001). TROSY NMR with partially
deuterated proteins. J. Biomol. NMR 20, 177–180.
Farrow, N.A., Muhandiram, R., Singer, A.U., Pascal, S.M., Kay, C.M., Gish, G.,
Shoelson, S.E., Pawson, T., Forman-Kay, J.D., and Kay, L.E. (1994). Backbone
dynamics of a free and phosphopeptide-complexed Src homology 2 domain
studied by 15N NMR relaxation. Biochemistry 33, 5984–6003.
Ferna´ndez, C., and Wider, G. (2003). TROSY in NMR studies of the structure
and function of large biological macromolecules. Curr. Opin. Struct. Biol. 13,
570–580.
Fontanini, A., Chies, R., Snapp, E.L., Ferrarini, M., Fabrizi, G.M., and
Brancolini, C. (2005). Glycan-independent role of calnexin in the intracellular
retention of Charcot-Marie-Tooth 1A Gas3/PMP22 mutants. J. Biol. Chem.
280, 2378–2387.
Fortun, J., Li, J., Go, J., Fenstermaker, A., Fletcher, B.S., and Notterpek, L.
(2005). Impaired proteasome activity and accumulation of ubiquitinated
substrates in a hereditary neuropathy model. J. Neurochem. 92, 1531–1541.
Fortun, J., Go, J.C., Li, J., Amici, S.A., Dunn, W.A., Jr., and Notterpek, L.
(2006). Alterations in degradative pathways and protein aggregation in all rights reserved
Structure
Structural Basis of Charcot-Marie-Tooth Diseaseneuropathy model based on PMP22 overexpression. Neurobiol. Dis. 22,
153–164.
Jetten, A.M., and Suter, U. (2000). The peripheral myelin protein 22 and epithe-
lial membrane protein family. Prog. Nucleic Acid Res. Mol. Biol. 64, 97–129.
Kay, L.E., Keifer, P., and Saarinen, T. (1992). Pure absorption gradient
enhanced heteronuclear single quantum correlation spectroscopy with
improved sensitivity. J. Am. Chem. Soc. 114, 10663–10665.
Korkhov, V.M., Milan-Lobo, L., Zuber, B., Farhan, H., Schmid, J.A.,
Freissmuth, M., and Sitte, H.H. (2008). Peptide-based interactions with cal-
nexin target misassembled membrane proteins into endoplasmic reticulum-
derived multilamellar bodies. J. Mol. Biol. 378, 337–352.
Li, Q., Su, Y.Y., Wang, H., Li, L., Wang, Q., and Bao, L. (2010). Transmembrane
segments prevent surface expression of sodium channel Nav1.8 and promote
calnexin-dependent channel degradation. J. Biol. Chem. 285, 32977–32987.
Longsworth, L.G. (1960). Themutual diffusion of light and heavywater. J. Phys.
Chem. 64, 1914–1917.
Mobley, C.K., Myers, J.K., Hadziselimovic, A., Ellis, C.D., and Sanders, C.R.
(2007). Purification and initiation of structural characterization of human
peripheral myelin protein 22, an integral membrane protein linked to peripheral
neuropathies. Biochemistry 46, 11185–11195.
Myers, J.K., Mobley, C.K., and Sanders, C.R. (2008). The peripheral neurop-
athy-linked Trembler and Trembler-Jmutant forms of peripheral myelin protein
22 are folding-destabilized. Biochemistry 47, 10620–10629.
Naef, R., and Suter, U. (1999). Impaired intracellular trafficking is a common
disease mechanism of PMP22 point mutations in peripheral neuropathies.
Neurobiol. Dis. 6, 1–14.
Notterpek, L., Ryan, M.C., Tobler, A.R., and Shooter, E.M. (1999). PMP22
accumulation in aggresomes: implications for CMT1A pathology. Neurobiol.
Dis. 6, 450–460.
Pareek, S., Notterpek, L., Snipes, G.J., Naef, R., Sossin, W., Laliberte´, J.,
Iacampo, S., Suter, U., Shooter, E.M., and Murphy, R.A. (1997). Neurons
promote the translocation of peripheral myelin protein 22 into myelin.
J. Neurosci. 17, 7754–7762.
Partridge, A.W., Therien, A.G., and Deber, C.M. (2002). Polar mutations in
membrane proteins as a biophysical basis for disease. Biopolymers 66,
350–358.
Redfield, C. (2004). Using nuclear magnetic resonance spectroscopy to study
molten globule states of proteins. Methods 34, 121–132.
Rohl, C.A., and Baldwin, R.L. (1997). Comparison of NH exchange and circular
dichroism as techniques for measuring the parameters of the helix-coil
transition in peptides. Biochemistry 36, 8435–8442.
Sakakura, M., Oo-Puthinan, S., Moriyama, C., Kimura, T., Moriya, J., Irimura,
T., and Shimada, I. (2008). Carbohydrate binding mechanism of the macro-
phage galactose-type C-type lectin 1 revealed by saturation transfer experi-
ments. J. Biol. Chem. 283, 33665–33673.
Salzmann, M., Wider, G., Pervushin, K., Senn, H., and Wuthrich, K. (1999).
TROSY-type triple-resonance experiments for sequential NMR assignments
of large proteins. J. Am. Chem. Soc. 121, 844–848.
Sanders, C.R. (2005). Post-integration misassembly of membrane proteins
and disease. In Protein-Lipid Interactions, L.K. Tamm, ed. (Berlin: Wiley-
VCH), pp. 81–94.
Sanders, C.R., and Myers, J.K. (2004). Disease-related misassembly of
membrane proteins. Annu. Rev. Biophys. Biomol. Struct. 33, 25–51.Structure 19, 1160–Sanders, C.R., Ismail-Beigi, F., and McEnery, M.W. (2001). Mutations of
peripheral myelin protein 22 result in defective trafficking through mechanisms
which may be common to diseases involving tetraspan membrane proteins.
Biochemistry 40, 9453–9459.
Schleucher, J., Schwendinger, M., Sattler, M., Schmidt, P., Schedletzky, O.,
Glaser, S.J., Sørensen, O.W., and Griesinger, C. (1994). A general enhance-
ment scheme in heteronuclear multidimensional NMR employing pulsed field
gradients. J. Biomol. NMR 4, 301–306.
Shen, Y., Delaglio, F., Cornilescu, G., and Bax, A. (2009). TALOS+: a hybrid
method for predicting protein backbone torsion angles from NMR chemical
shifts. J. Biomol. NMR 44, 213–223.
Strop, P., and Brunger, A.T. (2005). Refractive index-based determination of
detergent concentration and its application to the study ofmembrane proteins.
Protein Sci. 14, 2207–2211.
Suter, U., Moskow, J.J., Welcher, A.A., Snipes, G.J., Kosaras, B., Sidman,
R.L., Buchberg, A.M., and Shooter, E.M. (1992). A leucine-to-proline mutation
in the putative first transmembrane domain of the 22-kDa peripheral myelin
protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89, 4382–4386.
Swanton, E., High, S., andWoodman, P. (2003). Role of calnexin in the glycan-
independent quality control of proteolipid protein. EMBO J. 22, 2948–2958.
Tobler, A.R., Notterpek, L., Naef, R., Taylor, V., Suter, U., and Shooter, E.M.
(1999). Transport of Trembler-J mutant peripheral myelin protein 22 is blocked
in the intermediate compartment and affects the transport of the wild-type
protein by direct interaction. J. Neurosci. 19, 2027–2036.
Tobler, A.R., Liu, N., Mueller, L., and Shooter, E.M. (2002). Differential aggre-
gation of the Trembler and Trembler J mutants of peripheral myelin protein
22. Proc. Natl. Acad. Sci. USA 99, 483–488.
Valentijn, L.J., Baas, F., Wolterman, R.A., Hoogendijk, J.E., van den Bosch,
N.H., Zorn, I., Gabree¨ls-Festen, A.W., de Visser, M., and Bolhuis, P.A.
(1992). Identical point mutations of PMP-22 in Trembler-J mouse and
Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2, 288–291.
Weigelt, J. (1998). Single scan, sensitivity- and gradient-enhanced TROSY for
multidimensional NMR experiments. J. Am. Chem. Soc. 120, 10778–10779.
Wiseman, R.L., Powers, E.T., Buxbaum, J.N., Kelly, J.W., and Balch, W.E.
(2007). An adaptable standard for protein export from the endoplasmic retic-
ulum. Cell 131, 809–821.
Wishart, D.S., and Sykes, B.D. (1994). The 13C chemical-shift index: a simple
method for the identification of protein secondary structure using 13C chemi-
cal-shift data. J. Biomol. NMR 4, 171–180.
Wishart, D.S., Sykes, B.D., and Richards, F.M. (1991). Relationship between
nuclear magnetic resonance chemical shift and protein secondary structure.
J. Mol. Biol. 222, 311–333.
Wu, D.H., Chen, A.D., and Johnson, C.S. (1995). An improved diffusion-
ordered spectroscopy experiment incorporating bipolar-gradient pulses.
J. Magn. Reson. A 115, 260–264.
Zhou, N.E., Zhu, B.Y., Sykes, B.D., and Hodges, R.S. (1992). Relationship
between amide proton chemical-shifts and hydrogen-bonding in amphipathic
a-helical peptides. J. Am. Chem. Soc. 114, 4320–4326.
Zhu, G., Kong, X.M., and Sze, K.H. (1999). Gradient and sensitivity enhance-
ment of 2D TROSY with water flip-back, 3D NOESY-TROSY and TOCSY-
TROSY experiments. J. Biomol. NMR 13, 77–81.1169, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1169
